Analysis of the amount of tissue sample necessary for mitotic count and Ki-67 index in gastrointestinal stromal tumor sampling.

There are no established opinions concerning whether the amount of tissue affects the accuracy of histological analyses in gastrointestinal stromal tumors (GISTs). The aim of the present study was to investigate the appropriate amount of tissue sample needed for mitotic count based on the risk classification of GISTs and the Ki-67 index using the following three methods: endoscopic ultrasound-guided fine-needle aspiration (FNA), a novel sampling method called tunneling bloc biopsy (TBB), and biopsy forceps followed by TBB (Bf). Forty-three samples (12 FNA, 17 TBB and 14 Bf) diagnosed as GISTs by immunohistological analysis were utilized. The major and minor axes and overlay area of one piece of specimen (OPS) from the three sampling methods were measured using digital imaging software and were analyzed comparatively regarding the acquisition of histological data. The mean major and minor axes (mm) and overlay areas (mm2) were in the order of TBB > Bf > FNA. The evaluable rates by mitotic count and Ki-67 were, respectively, 75% (9/12) and 83.3% (10/12) for FNA samples, 100% (17/17) and 100% (17/17) for TBB samples, and 100% (14/14) and 100% (14/14) for Bf samples (P>0.05). Three FNA samples were judged unevaluable due to too small specimens in overall diagnosis including mitotic count and Ki-67, calculating the cut-off value for the overlay area of OPS as 0.17 mm2. Comparing the concordance rates between the pre- and post-operative samples, TBB samples was significantly better than FNA (P<0.05). Conclusively, while the amounts of tissues obtained by TBB and Bf are unnecessary for the histological assessment of mitotic count and Ki-67 index, developments of the FNA method are needed to minimize sample error. Considering the technical aspects, as well as the size of the specimens, could help to guide therapeutic planning and improve diagnostic yield for GI subepithelial tumors.

[1]  Y. Yatabe,et al.  Diagnostic utility of EUS-guided FNA in patients with gastric submucosal tumors. , 2010, Gastrointestinal endoscopy.

[2]  Y. Hirooka,et al.  The diagnosis of GI stromal tumors with EUS-guided fine needle aspiration with immunohistochemical analysis. , 2002, Gastrointestinal endoscopy.

[3]  S. Hirota,et al.  Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version , 2008, International Journal of Clinical Oncology.

[4]  T. Masaki,et al.  Establishment of pure NOTES procedure using a conventional flexible endoscope: review of six cases of gastric gastrointestinal stromal tumors. , 2011, Endoscopy.

[5]  J. Blay,et al.  Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  R. Bardales,et al.  Endoscopic ultrasound-guided fine-needle aspiration findings of gastrointestinal leiomyomas and gastrointestinal stromal tumors. , 2003, American journal of clinical pathology.

[7]  D. Faigel,et al.  EUS-guided sampling of suspected GI stromal tumors. , 2007, Gastrointestinal endoscopy.

[8]  J. Reguła,et al.  Diagnostic yield and safety of endoscopic ultrasound-guided trucut [corrected] biopsy in patients with gastric submucosal tumors: a prospective study. , 2009, Endoscopy.

[9]  W. Brugge,et al.  EUS-guided FNA for the diagnosis of GI stromal cell tumors: sensitivity and cytologic yield. , 2009, Gastrointestinal endoscopy.

[10]  C. Gostout,et al.  Submucosal endoscopy with mucosal flap safety valve. , 2007, Gastrointestinal endoscopy.

[11]  T. Masaki,et al.  Bloc biopsy by using submucosal endoscopy with a mucosal flap method for gastric subepithelial tumor tissue sampling (with video). , 2013, Gastrointestinal endoscopy.

[12]  K. Fu,et al.  Diagnosis of gastrointestinal stromal tumor by endoscopic ultrasound-guided fine needle aspiration biopsy--a potential pitfall. , 2002, Annals of diagnostic pathology.

[13]  M. Kimmey,et al.  The incidental upper gastrointestinal subepithelial mass. , 2004, Gastroenterology.

[14]  A. D. Van den Abbeele,et al.  NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. , 2007, Journal of the National Comprehensive Cancer Network : JNCCN.

[15]  J. Blay,et al.  Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment. , 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[16]  J. Lasota,et al.  Gastrointestinal stromal tumors: pathology and prognosis at different sites. , 2006, Seminars in diagnostic pathology.

[17]  L. Sobin,et al.  Diagnosis of gastrointestinal stromal tumors: A consensus approach. , 2002, Human pathology.

[18]  T. Masaki,et al.  Submucosal tunneling techniques: current perspectives , 2014, Clinical and experimental gastroenterology.

[19]  M. Kudo,et al.  Prospective comparative study of the EUS guided 25‐gauge FNA needle with the 19‐gauge Trucut needle and 22‐gauge FNA needle in patients with solid pancreatic masses , 2009, Journal of gastroenterology and hepatology.

[20]  J. Llach,et al.  Endoscopic ultrasound-guided fine-needle aspiration and trucut biopsy in the diagnosis of gastric stromal tumors: a randomized crossover study , 2010, Endoscopy.

[21]  R. Bardales,et al.  Endoscopic ultrasound-guided pancreatic duct aspiration: diagnostic yield and safety. , 2002, Endoscopy.

[22]  M. Schlemmer,et al.  Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.